Table 2.

Criteria for categorizing the efficacy of brand-name and compounded itraconazole formulations against Sporothrix brasiliensis, based on percentage of fungal inhibition in the in vitro antifungal susceptibility assay

Antifungal efficacy	Fungal inhibition (%)a
Very high	81–100
High	61–80
Moderate	41–60
Low	21–40
Very low	0–20

^aConsidering the total number of Sporothrix brasiliensis isolates tested (n = 29) as 100%